News
TrinityCare Senior Living, Inc. Announces Second Quarter Operating Results
August 17, 2010 2:45 am | by The Associated Press | Commentshttp://www.trinitycare.com () —TrinityCare Senior Living, Inc. (OTCBB: TCSR) (the "Company"), which develops, manages and owns faith-based senior living facilities, today announced its operating results for the second quarter of 2010.For the six months ended June 30, 2010, the Company reported...
Amarin Corporation Appoints Colin W. Stewart as President and Chief Executive Officer
August 17, 2010 12:33 am | by Bio-Medicine.Org | CommentsDUBLIN and MYSTIC, Conn., Aug. 17 /- Amarin Corporation plc (Nasdaq: AMRN ), a clinical-stage biopharmaceutical company with a focus on cardiovascular disease, today announced that Colin W. Stewart has been appointed President, Chief Executive Officer (CEO) and a member of the Company's...
Oridion to Present Results to New Study for the Integrated Pulmonary Index(TM) at ATACCC Conference
August 17, 2010 12:32 am | by Bio-Medicine.Org | CommentsOridion to Present Results to New Study for the Integrated Pulmonary... -- JERUSALEM and NEEDHAM, Massachusetts, August 17, 2010 /-
Delcath launches stock offering
August 16, 2010 5:45 pm | by The Associated Press | CommentsMedical device maker Delcath Systems Inc. said Monday it has started an offering of about 5.2 million shares to raise funds to pay for clinical trials, research and development and other costs.The offering is expected to close Aug. 20.Delcath has granted the underwriter a 30-day option to buy...
IMS Health names Bousbib as new CEO
August 16, 2010 1:45 pm | by The Associated Press | CommentsHealth-care market intelligence provider IMS Health Inc. on Monday said United Technologies Corp. executive Ari Bousbib will become its chief executive officer on Sept. 1.Bousbib, 48, was most recently president of United Technology's commercial companies, which include Otis Elevator Co. and...
FDA Proposes Withdrawal of Low Blood Pressure Drug
August 16, 2010 1:35 pm | by Bio-Medicine.Org | CommentsSILVER SPRING, Md., Aug. 16 /PRNewswire-USNewswire/ -- The U.S. Food and Drug Administration today proposed to withdraw approval of the drug midodrine hydrochloride, used to treat the low blood pressure condition orthostatic hypotension, because required post-approval studies that verify...
Midodrine hydrochloride: FDA Proposes Withdrawal of Low Blood Pressure Drug
August 16, 2010 1:31 pm | by U.S. Food & Drug Administration | CommentsCompanies failed to provide evidence of clinical benefit of midodrine hydrochloride because required post-approval studies that verify the clinical benefit of the drug have not been done.
Endologix Enters Development Agreement and Exclusive License for Balloon Expandable Stent Technology
August 16, 2010 10:34 am | by Bio-Medicine.Org | CommentsIRVINE, Calif., Aug. 16 /- Endologix, Inc. (Nasdaq: ELGX ), developer of minimally invasive treatments for aortic disorders, announced today that it has entered into a development agreement and exclusive license with Evasc Medical Systems Corp., for its balloon expandable stent...
Springer adds Neurotherapeutics to journals portfolio
August 16, 2010 10:33 am | by EurekAlert | Comments(Springer) Beginning in 2011, Springer will publish Neurotherapeutics, the official Journal of the American Society for Experimental NeuroTherapeutics. With the switch to Springer, Neurotherapeutics will change its format of publishing review articles only to offering original research...
PRA International Hosts Audio Conference on CV Drug Development
August 16, 2010 10:33 am | by Bio-Medicine.Org | CommentsRALEIGH, N.C., Aug. 16 /- PRA International, a leading Clinical Research Organization, will host an audio conference on strategies for successful cardiovascular (CV) drug development on 24 August 2010 at 11:30 am (EDT). Dr. Michael Kirchengast, Vice President and Head of PRA's Scientific...
NSF Awards $3M Stem Cell Bio-Manufacturing Program to Georgia Tech
August 16, 2010 10:33 am | by Georgia Tech Institute of Technology | CommentsThe NSF has awarded $3 million to Georgia Tech to fund a unique research program on stem cell bio-manufacturing. The effort is focused on developing engineering methods for stem cell production to meet the anticipated demand for stem cells.
VSL#3 Probiotic Shown Effective in Dietary Management of Children With Irritable Bowel Syndrome
August 16, 2010 10:33 am | by Bio-Medicine.Org | CommentsGAITHERSBURG, Md., Aug. 16 /PRNewswire-USNewswire/ -- New data show that VSL#3, a high-potency probiotic medical food, provides effective dietary management of children affected with irritable bowel syndrome (IBS). Â Until recently, little has been done to understand the role of...
Bruker Corp. spends $229M on Veeco business deal
August 16, 2010 7:45 am | by The Associated Press | CommentsScientific instruments maker Bruker Corp. has agreed to acquire a portion of the business of Veeco Instruments Inc. for $229 million in cash.The Billerica, Mass., company said Monday it will buy the Scanning Probe Microscopy and Optical Industrial Metrology instruments business in a deal it...
Nile Therapeutics Reports 2010 Second Quarter Financial Results
August 16, 2010 7:35 am | by Bio-Medicine.Org | CommentsSAN MATEO, Calif., Aug. 16 /- Nile Therapeutics, Inc. (Nasdaq: NLTX ), a company focused on the development of novel therapeutics for heart failure patients, today announced its second quarter financial results for 2010. Financial ResultsFor the three months ended June 30, 2010, Nile...
Interleukin Genetics Moves Trading of Stock to OTCQB Marketplace
August 16, 2010 7:35 am | by Bio-Medicine.Org | CommentsWALTHAM, Mass., Aug. 16 /- Interleukin Genetics, Inc. (OTCQB: ILIU) today announced that trading of shares of the Company's common stock will be transferred from the NYSE Amex to the OTCQB™ Marketplace effective today, August 16, 2010. Investors in the Company can trade the...
